Swiss outsourcing company Lonza has granted biotechnology firm
Genentech a non-exclusive, worldwide license to their Glutamine
Synthetase (GS) Gene Expression System which offers better yields,
speed and stability in cell protein...
A new family of objectives from Olympus specifically for Total
Internal Reflection Fluorescence Microscopy (TIRFM) can selectively
visualise processes and structures of the cell membrane, minimising
photo-damage and allowing cells...
Singapore's Ministry of Trade & Industry (MTI) will commit
$7.5bn (€63.1bn) over the next five years to drive R&D growth
in key industry areas such as biomedical science and increase
national R&D spending to 3 per...
Drug delivery company Chrono Therapeutics has unveiled a
wristwatch-like device for the non-invasive automatic
administration of drugs based on the amount and time instructed,
thus improving patience compliance.
India is emerging as a powerhouse of pharmaceutical R&D. Backed
by a scientist president and with an army of talented scientists,
the country now has R&D capacity second only to the US, at
one-fifth of the cost.
British company Q Chip has upped the stakes in the drug delivery
market with its new tailor-made bioencapsulation technology,
claiming to improve drug effectiveness, reduce side effects and
increase patient acceptance.
An insatiable Asian appetite for cell biology products has made
Fisher Scientific's cell-culture unit expand its Beijing facility,
making it the first non-native business to offer large-scale
liquid-media manufacturing in China.
A team of forensic pathologists are believed to be the world's
first to use a new radiological laboratory approach for mass
fatality investigations that could bring to the end current lab
methods that are slow and limited in...
The global market for microfiltration (MF) membranes used in liquid
separations is set to grow at an average annual rate of 9.4 per
cent to more than $1.2bn (€1bn) by 2010 from an estimated $792m in
2005 according to a new report,...
According to a new report, the adoption of eClinical technologies
has been hampered by the ability to take the electronic revolution
to the next level, as the adoption of eClinical technologies
currently remain confined to localised...
Drug developer Biosante has been awarded a $250,000 (€210,000)
subcontract from the University of Nebraska, Lincoln (UNL), to
develop recombinant Factor IX (FIX) formulations for delivery via
alternative routes of administration,...
Dutch instrumentation specialist PANalytical has added new options
to its X'Pert PRO MPD X-ray diffractometer, providing a total
solution for high throughput diffraction and analysing almost any